- Home
- CALC vs DXLG Comparison
CALC vs DXLG Comparison
Compare CALC & DXLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- DXLG
- Stock Information
- Founded
- CALC 2011
- DXLG 1976
- Country
- CALC United States
- DXLG United States
- Employees
- CALC N/A
- DXLG N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- DXLG Clothing/Shoe/Accessory Stores
- Sector
- CALC Health Care
- DXLG Consumer Discretionary
- Exchange
- CALC Nasdaq
- DXLG Nasdaq
- Market Cap
- CALC 48.1M
- DXLG 55.4M
- IPO Year
- CALC N/A
- DXLG 1987
- Fundamental
- Price
- CALC $3.09
- DXLG $1.26
- Analyst Decision
- CALC Strong Buy
- DXLG Strong Buy
- Analyst Count
- CALC 2
- DXLG 1
- Target Price
- CALC $14.50
- DXLG $2.50
- AVG Volume (30 Days)
- CALC 53.0K
- DXLG 206.5K
- Earning Date
- CALC 08-12-2025
- DXLG 08-27-2025
- Dividend Yield
- CALC N/A
- DXLG N/A
- EPS Growth
- CALC N/A
- DXLG N/A
- EPS
- CALC N/A
- DXLG N/A
- Revenue
- CALC N/A
- DXLG $447,744,000.00
- Revenue This Year
- CALC N/A
- DXLG N/A
- Revenue Next Year
- CALC N/A
- DXLG $3.56
- P/E Ratio
- CALC N/A
- DXLG N/A
- Revenue Growth
- CALC N/A
- DXLG N/A
- 52 Week Low
- CALC $1.42
- DXLG $0.90
- 52 Week High
- CALC $5.97
- DXLG $3.10
- Technical
- Relative Strength Index (RSI)
- CALC 56.35
- DXLG 46.45
- Support Level
- CALC $3.04
- DXLG $1.20
- Resistance Level
- CALC $3.38
- DXLG $1.47
- Average True Range (ATR)
- CALC 0.24
- DXLG 0.08
- MACD
- CALC 0.02
- DXLG -0.01
- Stochastic Oscillator
- CALC 58.57
- DXLG 22.22
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.